Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection.

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Zarruk JG
  • Fernández-López D
  • García-Yébenes I
  • García-Gutiérrez MS
  • Lizasoain I
  • Moro MA

Abstract

Ischemic stroke continues to be one of the main causes of death worldwide. Inflammation accounts for a large part of damage in this pathology. The cannabinoid type 2 receptor (CB2R) has been proposed to have neuroprotective properties in neurological diseases. Therefore, our aim was to determine the effects of the activation of CB2R on infarct outcome and on ischemia-induced brain expression of classic and alternative markers of macrophage/microglial activation.

Datos de la publicación

ISSN/ISSNe:
0039-2499, 1524-4628

Stroke  LIPPINCOTT WILLIAMS & WILKINS

Tipo:
Article
Páginas:
211-219
PubMed:
22020035
Factor de Impacto:
3,912 SCImago
Cuartil:
Q1 SCImago

Citas Recibidas en Web of Science: 185

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • ischemic stroke; MCAO; mouse; cannabinoid; microglia; alternative phenotype

Campos de Estudio

Compartir